Published in J R Soc Interface on October 22, 2006
Systems pathology--taking molecular pathology into a new dimension. Nat Rev Clin Oncol (2009) 1.06
Evaluation of multitype mathematical models for CFSE-labeling experiment data. Bull Math Biol (2011) 0.95
Quantitative analysis of the effects of iododeoxyuridine and ionising radiation treatment on the cell cycle dynamics of DNA mismatch repair deficient human colorectal cancer cells. IET Syst Biol (2013) 0.75
Analysis of cell cycle dynamics using probabilistic cell cycle models. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Mechanistic systems biology of inflammatory gene expression in airway smooth muscle as tool for asthma drug development. Curr Drug Discov Technol (2008) 0.75
Network biology: understanding the cell's functional organization. Nat Rev Genet (2004) 36.62
Universal control mechanism regulating onset of M-phase. Nature (1990) 19.11
An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci U S A (1981) 10.04
Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol (2002) 9.17
Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol (2003) 8.91
Genetic control of cell size at cell division in yeast. Nature (1975) 7.74
Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem Sci (1996) 7.54
Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harb Symp Quant Biol (1961) 6.43
Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat Cell Biol (2003) 5.86
Dominoes and clocks: the union of two views of the cell cycle. Science (1989) 5.74
Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol (1999) 5.62
Integrative analysis of cell cycle control in budding yeast. Mol Biol Cell (2004) 4.77
Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc Natl Acad Sci U S A (2002) 4.58
Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle (2003) 4.55
Network dynamics and cell physiology. Nat Rev Mol Cell Biol (2001) 4.22
Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol Biol Cell (2000) 3.63
Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J Cell Sci (1993) 3.53
Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol Biol Cell (1999) 3.41
Testing a mathematical model of the yeast cell cycle. Mol Biol Cell (2002) 3.23
Pattern formation in Escherichia coli: a model for the pole-to-pole oscillations of Min proteins and the localization of the division site. Proc Natl Acad Sci U S A (2001) 2.82
Modeling the cell division cycle: cdc2 and cyclin interactions. Proc Natl Acad Sci U S A (1991) 2.80
A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase. Proc Natl Acad Sci U S A (1991) 2.68
Ultrasensitivity in biochemical systems controlled by covalent modification. Interplay between zero-order and multistep effects. J Biol Chem (1984) 2.59
The regulation of cell size and the control of mitosis. J Theor Biol (1975) 2.50
Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol (2001) 2.42
The dynamics of cell cycle regulation. Bioessays (2002) 2.21
Modeling the control of DNA replication in fission yeast. Proc Natl Acad Sci U S A (1997) 2.04
Why cytoplasmic signalling proteins should be recruited to cell membranes. Trends Cell Biol (2000) 2.03
Signaling networks that link cell proliferation and cell fate. J Biol Chem (2002) 1.91
A model for restriction point control of the mammalian cell cycle. J Theor Biol (2004) 1.86
Analysis of a generic model of eukaryotic cell-cycle regulation. Biophys J (2006) 1.86
Modular analysis of the transcriptional regulatory network of E. coli. Trends Genet (2005) 1.83
Cell cycle control genes in fission yeast and mammalian cells. Trends Genet (1988) 1.77
The cell cycle and cancer. Proc Natl Acad Sci U S A (1997) 1.72
Four-dimensional organization of protein kinase signaling cascades: the roles of diffusion, endocytosis and molecular motors. J Exp Biol (2003) 1.70
Cell division from a genetic perspective. J Cell Biol (1978) 1.68
Diffusion control of protein phosphorylation in signal transduction pathways. Biochem J (2000) 1.66
Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am J Physiol Cell Physiol (2002) 1.58
Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys J (2003) 1.47
Modeling the fission yeast cell cycle: quantized cycle times in wee1- cdc25Delta mutant cells. Proc Natl Acad Sci U S A (2000) 1.41
A model for a bistable biochemical trigger of mitosis. Biophys Chem (1996) 1.40
On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry (2000) 1.35
MAP kinase cascade signaling and endocytic trafficking: a marriage of convenience? Trends Cell Biol (2002) 1.27
The kinetic origins of the restriction point in the mammalian cell cycle. Cell Prolif (1999) 1.23
Ingeneue: a versatile tool for reconstituting genetic networks, with examples from the segment polarity network. J Exp Zool (2002) 1.06
Covalent modification of proteins as a threshold mechanism in development. J Theor Biol (1990) 1.05
A stochastic, molecular model of the fission yeast cell cycle: role of the nucleocytoplasmic ratio in cycle time regulation. Biophys Chem (2001) 1.02
The ups and downs of modeling the cell cycle. Curr Biol (2004) 1.00
Molecular aspects of the mammalian cell cycle and cancer. Oncologist (2002) 1.00
Finishing the cell cycle. J Theor Biol (1999) 0.99
Linking cell division to cell growth in a spatiotemporal model of the cell cycle. J Theor Biol (2006) 0.94
A mathematical description of regulation of the G1-S transition of the mammalian cell cycle. Biotechnol Bioeng (1999) 0.93
Instabilities in phosphorylation-dephosphorylation cascades and cell cycle checkpoints. Oncogene (1999) 0.91
Mathematical analysis of binary activation of a cell cycle kinase which down-regulates its own inhibitor. Biophys Chem (1999) 0.91
Alternating oscillations and chaos in a model of two coupled biochemical oscillators driving successive phases of the cell cycle. Ann N Y Acad Sci (1999) 0.90
Modeling genetic switches with positive feedback loops. J Theor Biol (2003) 0.89
Allosteric regulation, cooperativity, and biochemical oscillations. Biophys Chem (1990) 0.88
Theoretical dynamics of the cyclin B-MPF system: a possible role for p13suc1. Biosystems (1994) 0.88
Modelling periodic oscillation of biological systems with multiple timescale networks. Syst Biol (Stevenage) (2004) 0.87
A framework for whole-cell mathematical modeling. J Theor Biol (2004) 0.86
Complex oscillatory phenomena, including multiple oscillations, in regulated biochemical systems. Biomed Biochim Acta (1985) 0.86
Initiation of synchronous mitosis in Physarum polycephalum. A model of the control of cell division in eukariots. Exp Cell Res (1972) 0.85
Timing the changes of cyclin E cell content in G1 in exponentially growing cells. Exp Cell Res (2003) 0.81
Mathematical analysis of a model of the mitotic clock. Science (1991) 0.80
Finding complex oscillatory phenomena in biochemical systems. An empirical approach. Biophys Chem (1988) 0.80
Models of cell cycle control in eukaryotes. J Biotechnol (1999) 0.77
Oscillatory dynamics in intercellular communication. Biomed Biochim Acta (1990) 0.76
Kick-starting the cell cycle: From growth-factor stimulation to initiation of DNA replication. Chaos (2001) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Drug discovery and p53. Drug Discov Today (2003) 2.34
Three-dimensional microorganization of the soil-root-microbe system. Microb Ecol (2006) 2.33
Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell (2006) 2.09
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int J Cancer (2002) 1.84
Biomass recycling and the origin of phenotype in fungal mycelia. Proc Biol Sci (2005) 1.76
DNA-dependent acetylation of p53 by the transcription coactivator p300. J Biol Chem (2002) 1.59
Visualization, modelling and prediction in soil microbiology. Nat Rev Microbiol (2007) 1.59
The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo. J Biol Chem (2002) 1.50
The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics (2004) 1.42
Bioluminescent imaging of Cdk2 inhibition in vivo. Nat Med (2004) 1.37
The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53. Mol Cell Biol (2003) 1.33
Spatial distribution of bacterial communities and their relationships with the micro-architecture of soil. FEMS Microbiol Ecol (2003) 1.32
Hypoxia attenuates the p53 response to cellular damage. Oncogene (2003) 1.31
Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin. Cancer Res (2010) 1.27
Continuous time random walk model better describes the tailing of atrazine transport in soil. Chemosphere (2008) 1.21
CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. J Biol Chem (2009) 1.19
DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J Biol Chem (2008) 1.19
Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53. Mol Cell Biol (2004) 1.16
The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours? Semin Cancer Biol (2009) 1.13
The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway. Aging (Albany NY) (2009) 1.12
Systems pathology--taking molecular pathology into a new dimension. Nat Rev Clin Oncol (2009) 1.06
The effects of fungal inoculum arrangement (scale and context) on emergent community development in an agar model system. FEMS Microbiol Ecol (2002) 1.04
p63: the phantom of the tumor suppressor. Cell Cycle (2007) 1.04
Drug discovery and mutant p53. Trends Cell Biol (2010) 1.04
The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members. Mol Cell Biol (2007) 1.01
A function for the RING finger domain in the allosteric control of MDM2 conformation and activity. J Biol Chem (2009) 1.01
How phosphorylation controls p53. Cell Cycle (2011) 0.99
Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death. FEBS J (2009) 0.97
A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection. J Biol Chem (2008) 0.96
The emergence of the conserved AAA+ ATPases Pontin and Reptin on the signaling landscape. Sci Signal (2013) 0.94
Anomalous diffusion of heterogeneous populations characterized by normal diffusion at the individual level. J R Soc Interface (2009) 0.93
Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2. Biochem J (2004) 0.90
Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif. J Chem Biol (2009) 0.90
Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. J Immunol Methods (2012) 0.90
A divergent substrate-binding loop within the pro-oncogenic protein anterior gradient-2 forms a docking site for Reptin. J Mol Biol (2010) 0.89
On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding. J Mol Biol (2005) 0.89
The calcium-binding domain of the stress protein SEP53 is required for survival in response to deoxycholic acid-mediated injury. FEBS J (2006) 0.89
p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program. Cell Cycle (2011) 0.89
Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo. Biochem J (2006) 0.89
Domain-decomposition method for parallel lattice Boltzmann simulation of incompressible flow in porous media. Phys Rev E Stat Nonlin Soft Matter Phys (2005) 0.88
DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation. Mol Cancer (2010) 0.88
Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulation. Cell Cycle (2011) 0.87
Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2. Cancer Lett (2013) 0.87
Modelling interactions in fungi. J R Soc Interface (2008) 0.87
Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein. J Mol Biol (2004) 0.86
Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription. Exp Biol Med (Maywood) (2012) 0.86
Chemical genetics approach to identify peptide ligands that selectively stimulate DAPK-1 kinase activity. Biochemistry (2007) 0.85
ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1. FEBS J (2008) 0.85
Identification of two reactive cysteine residues in the tumor suppressor protein p53 using top-down FTICR mass spectrometry. J Am Soc Mass Spectrom (2011) 0.85
Cancer systems biology. Methods Mol Biol (2010) 0.84
The small Rho GTPase Rac1 controls normal human dermal fibroblasts proliferation with phosphorylation of the oncoprotein c-myc. Biochem Biophys Res Commun (2007) 0.84
The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2. J Mol Biol (2010) 0.84
The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain. J Biol Chem (2004) 0.84
CK2-site phosphorylation of p53 is induced in DeltaNp63 expressing basal stem cells in UVB irradiated human skin. Cell Cycle (2006) 0.84
The alternative splice variant of DAPK-1, s-DAPK-1, induces proteasome-independent DAPK-1 destabilization. Mol Cell Biochem (2009) 0.84
A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1. J Biol Chem (2011) 0.84
Evaluating DAPK as a therapeutic target. Apoptosis (2014) 0.83
Microarray-formatted clinical biomarker assay development using peptide aptamers to anterior gradient-2. Biochemistry (2007) 0.83
Resource seeking strategies of zoosporic true fungi in heterogeneous soil habitats at the microscale level. Soil Biol Biochem (2012) 0.82
Signaling to p53: the use of phospho-specific antibodies to probe for in vivo kinase activation. Methods Mol Biol (2003) 0.82
Effects of the cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) on the physiology of cultured human keratinocytes. Biochem Pharmacol (2005) 0.81
A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function. J Biol Chem (2010) 0.81
Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry. Proteomics (2013) 0.80
Intrasteric regulation of MDM2. Trends Biochem Sci (2003) 0.80
Nanosensing protein allostery using a bivalent mouse double minute two (MDM2) assay. Proc Natl Acad Sci U S A (2012) 0.80
Modelling nematode movement using time-fractional dynamics. J Theor Biol (2007) 0.79
Exploiting the MDM2-CK1α protein-protein interface to develop novel biologics that induce UBL-kinase-modification and inhibit cell growth. PLoS One (2012) 0.79
A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53. J Biol Chem (2010) 0.79
A novel ataxia-telangiectasia mutated autoregulatory feedback mechanism in murine embryonic stem cells. J R Soc Interface (2009) 0.79
Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer. Cell Signal (2012) 0.79
The molecular dynamics of MDM2. Cell Cycle (2010) 0.79
Engineering a synthetic cell panel to identify signalling components reprogrammed by the cell growth regulator anterior gradient-2. Mol Biosyst (2014) 0.79
Multienzyme assembly of a p53 transcription complex. Nat Struct Mol Biol (2007) 0.78
Novel insights into DAPK autophagic signalling using peptide aptamer combinatorial protein-interaction screens. Autophagy (2008) 0.78
Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagus. Eur J Gastroenterol Hepatol (2008) 0.77
The regulation of CHK2 in human cancer. Oncogene (2004) 0.77
Development of a fluorescent monoclonal antibody-based assay to measure the allosteric effects of synthetic peptides on self-oligomerization of AGR2 protein. Protein Sci (2013) 0.77
Quantitative proteomic profiling of pleomorphic human sarcoma identifies CLIC1 as a dominant pro-oncogenic receptor expressed in diverse sarcoma types. J Proteome Res (2014) 0.77
Effects of the CDK-inhibitor CYC202 on p38 MAPK, ERK1/2 and c-Myc activities in papillomavirus type 16 E6- and E7-transformed human keratinocytes. Oncol Rep (2007) 0.76
A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway. Bioorg Med Chem Lett (2013) 0.76
Modelling fungal colonies and communities: challenges and opportunities. IMA Fungus (2010) 0.75
The D153del mutation in GNB3 gene causes tissue specific signalling patterns and an abnormal renal morphology in Rge chickens. PLoS One (2011) 0.75
Assessment of left ventricular structure and function in rats subjected to pressure-overload hypertrophy in time. Kardiol Pol (2009) 0.75
Erratum: CHIP-dependent regulation of the actin cytoskeleton is linked to neuronal cell membrane integrity. iScience (2022) 0.75
Protein kinases coordinately regulate the p53: Delta Np63 alpha axis after DNA damage. Cell Cycle (2008) 0.75
Toward a synthetic economic systems modeling tool for sustainable exploitation of ecosystems. Ann N Y Acad Sci (2011) 0.75